Causal Inference Seminar: Peter Tennant Oxford Population Health 2026-09-23 | Causal Inference Seminar: Peter Tennant
Algorithm for identifying breast cancer recurrences Oxford Population Health 2025-10-01 | In this video, Gurdeep S. Mannu explains how researchers at Oxford Population Health have developed an algorithm to identify different types of breast cancer recurrences using cancer registry data. This could speed up research, support policy decisions, and give better insights into breast cancer recurrences.
The AMALFI trial explained Oxford Population Health 2025-08-29 | Atrial fibrillation (AF) is a common heart condition that often goes undetected. New research from Oxford Population Health shows that home-based ECG patch screening can improve the diagnosis and treatment of AF in older adults with known stroke risk factors. The AMALFI trial, published in JAMA and presented at the ESC Congress 2025, highlights the potential of remote monitoring to detect AF earlier and support timely access to protective treatment — all without disrupting daily life.Learn more about the trial👉 bit.ly/41tbDVS
RECOVERY Collaborators Meeting Monday 12 and Tuesday 13 May 2025 Update and Future Plans Meeting Oxford Population Health 2025-05-27 | ...
Rositsa Koleva-Kolarova – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
Sarah Wordsworth – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
Padraig Dixon – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
John Buckell – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
Sally Sansom – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
Frederick McElwee – HERC Health Economics and Genomics Seminar 2024 Oxford Population Health 2025-02-13 | ...
ASCEND ANYWHERE PARTICIPANT VIDEO Oxford Population Health 2025-01-24 | A short video explaining how to use Attend Anywhere software to conduct video calls during the ASCEND PLUS trial.
Cecilia Lindgren Professorial Inaugural Lecture, 20 June 2018 Oxford Population Health 2024-12-05 | ...
RECOVERY trial collaborators meeting, Tuesday 15 October 2024 Oxford Population Health 2024-11-22 | ...
Shaping Your Research Questions: Insights from a DPhil Student’s Problem-Based Approach Oxford Population Health 2024-11-11 | Danial Qureshi, a DPhil student at the University of Oxford, shares his experience with a problem-based learning approach—developing focused research questions and using available resources to build expertise in a specific area. He reflects on how these skills are essential for a future academic career.Danial also offers practical advice for prospective applicants, emphasising the importance of choosing the right supervisor. From understanding working styles to speaking with former students, he highlights how a strong supervisory relationship can shape the entire DPhil experience.🔗 Learn more about the DPhil in Population Health hosted by Oxford Population Health: ndph.ox.ac.uk/study-with-us/dphil-population-health
Crossing Disciplines and Institutions: A DPhil Student’s Collaborative Approach Beyond Academia Oxford Population Health 2024-11-11 | Trishna Desai, a DPhil student at the University of Oxford, shares her journey researching molecular and proteomic risk factors for prostate cancer within the Cancer Epidemiology Unit at Oxford Population Health. She emphasises the importance of large-scale, high-quality data in addressing key questions about chronic disease risk and prevention, while reflecting on the collaborative nature of her project—spanning departments, disciplines, and institutions.Trishna also provides practical advice for prospective applicants, including tips on choosing the right supervisor and developing a research proposal that fosters growth and curiosity. Her story highlights the supportive and intellectually stimulating environment at Oxford Population Health.🔗 Learn more about the DPhil in Population Health offered by Oxford Population Health: ndph.ox.ac.uk/study-with-us/dphil-population-health
A Place for Real Research: Student Journeys with MSc in Global Health Science and Epidemiology Oxford Population Health 2024-09-25 | Hear from students on the MSc in Global Health Science and Epidemiology at the University of Oxford, as they share what drew them to the course and how it shaped their academic and personal journeys.Through a fast-paced, intensive year, they gained confidence in biostatistics and epidemiology, discovered new areas of interest — including genetic epidemiology — and tapped into Oxford’s unique data resources like the Big Data Institute and UK Biobank.Alongside academic insights, students offer practical guidance for future applicants — emphasising the importance of understanding your learning goals and ensuring the MSc is the right fit for your research aspirations.🎓 Learn more about the MSc in Global Health Science and Epidemiology hosted by Oxford Population Health (Nuffield Department of Population Health, NDPH) ndph.ox.ac.uk/study-with-us/MSc-GHSE
Alumni Insights: Why Choose MSc in Clinical Trials at Oxford? Oxford Population Health 2024-09-10 | Why do experienced clinicians from around the world choose Oxford’s MSc in Clinical Trials? In this video, alumni share how the course has helped them elevate their careers, deepen their expertise, and bring cutting-edge research to their clinical practice.From expanding high-volume cardiac centres in Malaysia to becoming principal investigators in global trials, they reflect on the importance of evidence-based medicine and the role of research in improving patient care. They also explain how Oxford's teaching, resources, and academic environment empower healthcare professionals to lead impactful studies and drive innovation. Whether you're aiming to move into research or strengthen the role of trials in your institution, this programme provides the foundation to make it happen.
EASi KIDNEY Introduction Oxford Population Health 2024-07-15 | EASi-KIDNEY is an international, multi-centre, randomised double-blind placebo-controlled trial which will assess whether a new drug, currently called BI 690517, reduces the risk of kidney disease progression, hospitalisation for heart failure or death from cardiovascular disease in people with chronic kidney disease when it is added to standard care including empagliflozin.Read more at easikidney.org
